Skip to main content
SpringerLink
Log in

Kein erhöhtes Risiko schwerer Infektionen unter Biologikatherapie bei Psoriasis

No increased risk of severe infections under biologic therapies in psoriasis

  • Journal Club
  • Published:
Der Hautarzt Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Fathi R, Armstrong AW (2015) The role of biologic therapies in dermatology. Med Clin North Am 6:1183–1194

    Article  Google Scholar 

  2. Dávila-Seijo P, Dauden E et al (2017) Infections in moderate to severe psoriasis patients treated with biological drugs compared to classic systemic drugs: findings from the BIOBADADERM registry. J Invest Dermatol 2:313–321

    Article  CAS  Google Scholar 

  3. Singh JA, Cameron C et al (2015) Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis. Lancet 99(0):258–265

    Article  Google Scholar 

  4. Galloway JB, Hyrich KL et al (2010) Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly

Download references

Author information

Authors and Affiliations

  1. Universitäts-Hautklinik, Liebermeisterstr. 25, 72076, Tübingen, Deutschland

    D. Sossau &  A. S. Yazdi

Authors
  1. D. Sossau
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. S. Yazdi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. S. Yazdi.

Ethics declarations

Interessenkonflikt

D. Sossau und A.S. Yazdi geben an, dass kein Interessenkonflikt besteht.

Additional information

Redaktion

J. Krutmann, Düsseldorf

Redaktionelle Mitarbeit

R. Gläser, Kiel

B. Homey, Düsseldorf

E. Makrantonaki, Ulm

B. Wedi, Hannover

A.S. Yazdi, Tübingen

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sossau, D., Yazdi, A.S. Kein erhöhtes Risiko schwerer Infektionen unter Biologikatherapie bei Psoriasis. Hautarzt 69, 609–610 (2018). https://doi.org/10.1007/s00105-018-4209-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00105-018-4209-3

Search

Navigation